Viewing Study NCT02140333


Ignite Creation Date: 2025-12-25 @ 3:04 AM
Ignite Modification Date: 2026-03-05 @ 10:15 PM
Study NCT ID: NCT02140333
Status: UNKNOWN
Last Update Posted: 2015-02-12
First Post: 2013-10-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC
Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module